Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Sorrento Therpt (SRNE)

4.95   -0.1 (-1.98%) 06-01 11:35
Open: 4.96 Pre. Close: 5.05
High: 5.12 Low: 4.89
Volume: 6,897,578 Market Cap: 1,038M
Sorrento Therapeutics Inc is a biotechnology company focused on the development of novel immunotherapies for oncology and autoimmune/inflammation diseases.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 5.093 - 5.118 5.118 - 5.143
Low: 4.753 - 4.778 4.778 - 4.804
Close: 5.008 - 5.049 5.049 - 5.091

Technical analysis

as of: 2020-06-01 11:02:53 AM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 8.19     One year: 11.68
Support: Support1: 2.18    Support2: 1.81
Resistance: Resistance1: 7.01    Resistance2: 10.00
Pivot: 4.72
Moving Average: MA(5): 5.07     MA(20): 4.16
MA(100): 3.01     MA(250): 2.71
MACD: MACD(12,26): 0.69     Signal(9): 0.69
Stochastic oscillator: %K(14,3): 33.09     %D(3): 34.77
RSI: RSI(14): 59.47
52-week: High: 10.00  Low: 1.39  Change(%): 61.7
Average Vol(K): 3-Month: 2624450  10-Days: 7238107

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
SRNE has closed below upper band by 46.6%. Bollinger Bands are 215% wider than normal. The large width of the bands suggest high volatility as compared to SRNE's normal range. The bands have been in this wide range for 10 bars. This is a sign that the current trend might continue.

Headline News

Mon, 18 May 2020
Sorrento (SRNE) Stock Is up 140% in Two Days. How Much Higher Can It Go? - Yahoo Finance

Wed, 20 May 2020
Better Coronavirus Stock: Moderna vs. Sorrento Therapeutics - Motley Fool

Fri, 08 May 2020
Sorrento And Mount Sinai Health System To Jointly Develop COVI-SHIELD™ Antibody Therapy Targeting SARS-CoV-2 Infection (COVID-19) - PRNewswire

Wed, 20 May 2020
Sorrento: Great Time For A Capital Raise - Seeking Alpha

Tue, 26 May 2020
Sorrento’s COVID-19 Antidote Could be a Game Changer, Says Analyst - Yahoo Finance

Fri, 15 May 2020
Sorrento blitzed reporters with embargoed pitches on COVID cure - Feuerstein - Seeking Alpha

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 210
Shares Float (M) 145
% Held by Insiders 34.21
% Held by Institutions 17.86
Shares Short (K) 24,200
Shares Short P. Month (K) 23,830

Stock Financials

EPS -1.950
EPS Est This Year -1.070
EPS Est Next Year -0.650
Book Value (p.s.) 0.510
Profit Margin
Operating Margin -577.03
Return on Assets (ttm) -20.8
Return on Equity (ttm) -337.4
Qtrly Rev. Growth 25.7
Gross Profit (p.s.) -0.418
Sales Per Share 0.157
EBITDA (p.s.) -0.858
Qtrly Earnings Growth
Operating Cash Flow (M) -167
Levered Free Cash Flow (M) -115

Stock Valuations

PE Ratio -2.51
PEG Ratio
Price to Book value 9.61
Price to Sales 31.13
Price to Cash Flow -6.14

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.